Analytical Data
-
Gene name
NARG1L
- Application
-
Alternative Names
NAA16; NARG1L; NAT2; N-alpha-acetyltransferase 16; NatA auxiliary subunit; NMDA receptor-regulated 1-like protein; NARG1-like protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6N069
-
Expression Region
1-311 aa
-
AA Sequence
MPNVLLPPKESNLFKRILKCYEQKQYKNGLKFCKMILSNPKFAEHGETLAMKGLTLNCLGKKEEAYEFVRKGLRNDVKSHVCWHVYGLLQRSDKKYDEAIKCYRNALKLDKDNLQILRDLSLLQIQMRDLEGYRETRYQLLQLRPTQRASWIGYAIAYHLLKDYDMALKLLEEFRQTQQVPPNKIDYEYSELILYQNQVMREADLLQESLEHIEMYEKQICDKLLVEEIKGEILLKLGRLKEASEVFKNLIDRNAENWCYYEGLEKALQISTLEERLQIYEEISKQHPKAITPRRLPLTLVPGFYNPGTCY
-
Molecular Weight
63.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NARG1L, or NAC domain containing protein 1-like, is a key player in various biological processes, including cellular differentiation and survival. It has gained attention in recent years due to its involvement in neuronal development and its potential role in neurodegenerative diseases. Research indicates that NARG1L participates in the regulation of several signaling pathways, including those linked to stress responses and apoptosis, making it a significant target for therapeutic explorations. The study of recombinant NARG1L protein is crucial for understanding its biochemical properties and physiological functions, facilitating the investigation of its mechanisms in health and disease. By producing and analyzing this recombinant protein, researchers aim to elucidate its role in different cellular contexts and explore its potential as a biomarker or therapeutic target. Given the rising interest in protein-based therapies, NARG1L holds promise for contributing to innovative treatments for conditions where its dysregulation is implicated. Thus, the ongoing research into NARG1L recombinant proteins is pivotal for advancing our knowledge of its functions and implications in molecular biology and medicine.
